comparemela.com

Tom Dubensky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tempest Announces Expanded Role for Sam Whiting, M D , Ph D , as Chief Medical Officer and Head of Research and Development

19.09.2023 - BRISBANE, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) - Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics that combine both targeted and immune-mediated mechanisms, announced today . Seite 1

Synthetic Biologics Reports First Quarter 2022 Operational

2022-05-05 | NYSEAM:SYN | Press Release | Synthetic Biologics Inc

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.